Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer

PURPOSE: Gemcitabine, cisplatin, and S‐1 chemotherapy was superior to gemcitabine and cisplatin chemotherapy for progression‐free survival and overall survival for unresectable and recurrent biliary tract cancer in a randomized phase III trial (KHBO1401). This study aimed to evaluate the outcome of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Ikuo, Hatano, Etsuro, Baba, Hideo, Kamei, Keiko, Wada, Hiroshi, Shimizu, Junzo, Kanai, Masashi, Yoshimura, Kenichi, Nagano, Hiroaki, Ioka, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623972/
https://www.ncbi.nlm.nih.gov/pubmed/37927929
http://dx.doi.org/10.1002/ags3.12713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623972/
https://www.ncbi.nlm.nih.gov/pubmed/37927929
http://dx.doi.org/10.1002/ags3.12713

Ejemplares similares